Cognitive and neurological outcome of patients in the Dutch pyridoxine-dependent epilepsy (PDE-ALDH7A1) cohort, a cross- sectional study

Background: Pyridoxine monotherapy in PDE-ALDH7A1 often results in adequate seizure control, but neurodevelopmental outcome varies. Detailed long-term neurological outcome is unknown. Here we present the cognitive and neurological features of the Dutch PDE-ALDH7A1 cohort. Methods: Neurological outcome was assessed in 24 patients (age 1-26 years); classified as normal, complex minor neurological dysfunction (complex MND) or abnormal. Intelligence quotient (IQ) was derived from standardized IQ tests with five severity levels of intellectual disability (ID). MRI's and treatments were assessed. Re... Mehr ...

Verfasser: Strijker, M.
Tseng, L. A.
van Avezaath, L. K.
Luttikhuis, M. A. M. Oude
Ketelaar, T.
Coughlin, C. R.
Coenen, M. A.
van Spronsen, F. J.
Williams, M.
de Vries, M. C.
Westerlaan, H. E.
Bok, L. A.
van Karnebeek, C. D. M.
Lunsing, R. J.
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Reihe/Periodikum: Strijker , M , Tseng , L A , van Avezaath , L K , Luttikhuis , M A M O , Ketelaar , T , Coughlin , C R , Coenen , M A , van Spronsen , F J , Williams , M , de Vries , M C , Westerlaan , H E , Bok , L A , van Karnebeek , C D M & Lunsing , R J 2021 , ' Cognitive and neurological outcome of patients in the Dutch pyridoxine-dependent epilepsy (PDE-ALDH7A1) cohort, a cross- sectional study ' , European Journal of Paediatric Neurology , vol. 33 , pp. 112-120 . https://doi.org/10.1016/j.ejpn.2021.06.001
Schlagwörter: Pyridoxine-dependent epilepsy / Vitamin B6 / Neurological outcome / Lysine reduction therapies / Intellectual disability / MRI / LYSINE-RESTRICTED DIET / ARGININE SUPPLEMENTATION / SEIZURES / THERAPY / MUTATIONS / ANTIQUITIN / PHENOTYPE / DIAGNOSIS / LEADS
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26671551
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/11370/b0c964d1-abaa-4bf1-ab37-cd095d9d4a9b